A large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with ...

Tirzepatide and semaglutide are type 2 diabetes drugs often used for weight loss. While tirzepatide may potentially be more effective, it's too early to know that based on current research.

Tirzepatide was initiated at a dose of 2.5 mg once weekly, and the dose was increased by 2.5 mg every 4 weeks until a maximum tolerated dose of 10 mg or 15 mg was reached (Fig. S1 in the ...

NEW ORLEANS — For people with type 2 diabetes (T2D) inadequately controlled on submaximal dulaglutide (Trulicity) doses, switching to tirzepatide (Mounjaro) produces significantly greater A1c ...

The substudy included patients with ABPM available at baseline and week 36 who had been randomly assigned to four treatment groups: placebo (n=155), tirzepatide 5 mg (n=145), tirzepatide 10 mg (n ...

Tirzepatide was initiated at a dose of 2.5 mg once weekly (or matching placebo) and was increased by 2.5 mg every 4 weeks during the dose-escalation period to reach a maintenance dose of up to 15 ...

The medium-dose group lost 49 pounds, and the low-dose group lost 35 pounds. And 63 percent of participants taking tirzepatide 15 mg achieved at least 20 percent body weight reductions.